Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ EchoStar Announces Spectrum Sale and Commercial Agreement with SpaceX (PR Newswire) +++ ECHOSTAR Aktie +26,96%

SHANGHAI FOSUN PHARMACEUTICAL Aktie

 >FOSUN PHARMA Aktienkurs 
2.964 EUR    +12.8%    (Tradegate)
Ask: 2.964 EUR / 2024 Stück
Bid: 2.818 EUR / 2131 Stück
Tagesumsatz: 2841 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
FOSUN PHARMA Aktie über LYNX handeln
>FOSUN PHARMA Performance
1 Woche: +7,0%
1 Monat: +21,8%
3 Monate: +40,8%
6 Monate: +40,5%
1 Jahr: +85,2%
laufendes Jahr: +48,2%
>FOSUN PHARMA Aktie
Name:  SHANGHAI FOSUN PHARMACEUTICAL
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  CNE100001M79 / A1J68D
Symbol/ Ticker:  08HH (Frankfurt)
Kürzel:  FRA:08HH, ETR:08HH, 08HH:GR
Index:  -
Webseite:  https://www.fosunpharma.c..
Profil:  Shanghai Fosun Pharmaceutical Group Co., Ltd. is a..
>Volltext..
Marktkapitalisierung:  9095.53 Mio. EUR
Unternehmenswert:  13097.16 Mio. EUR
Umsatz:  4688.24 Mio. EUR
EBITDA:  660.89 Mio. EUR
Nettogewinn:  380.89 Mio. EUR
Gewinn je Aktie:  0.14 EUR
Schulden:  4422.5 Mio. EUR
Liquide Mittel:  1543.05 Mio. EUR
Operativer Cashflow:  570.1 Mio. EUR
Bargeldquote:  0.45
Umsatzwachstum:  -10.57%
Gewinnwachstum:  59.14%
Dividende je Aktie:  0.04 EUR
Dividendenrendite:  1.45%
Dividendenschätzung:  1.45%
Div. Historie:  24.07.25 - 0.0379785€
26.07.24 - 0.035604€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  SHANGHAI FOSUN PHARMACEUTICAL, SHANGHAI FOSUN PHARMA, FOSUN PHARMA
Letzte Datenerhebung:  08.09.25
>FOSUN PHARMA Kennzahlen
Aktien/ Unternehmen:
Aktien: 540.97 Mio. St.
Frei handelbar: 85.84%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 40557
Umsatz/Mitarb.: 0.12 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 3.5%
Bewertung:
KGV: 18.27
KGV lG: 17.34
KUV: 1.37
KBV: -
PEG-Ratio: 0.22
EV/EBITDA: 19.82
Rentabilität:
Bruttomarge: 47.37%
Gewinnmarge: 8.12%
Operative Marge: 5.72%
Managementeffizenz:
Gesamtkaprendite: 2.76%
Eigenkaprendite: 6.85%
>FOSUN PHARMA Peer Group

Es sind 101 Aktien bekannt.
 
08.09.25 - 06:15
Midday Takeaway: HSI Closes Midday at 25,508, Up 90 pts; HSTI Closes Midday at 5,702, Up 15 pts; BABA Up over 3%; WUXI BIO, CHOW TAI FOOK, FOSUN PHARMA, HORIZONROBOT-W, CHINA LESSO Hit New Highs (AAStocks)
 
At midday close, HSI rose 90 pts or 0.4% to 25,508. HSTI rose 15 pts or 0.3% to 5,702. HSCEI gained 15 pts or 0.2% to 9,072.Active Heavyweights:BABA (09988.HK) closed at $136.7, up 3.7%XIAOMI (01810.HK) closed at $54.3, up 1.2%TENCENT (00700.HK) closed at $612, up 1.1%MEITUAN (03690.HK) closed at $102.5, down 0.5%HSI & HSCEI Con......
28.08.25 - 05:30
Research: CLSA: FOSUN PHARMA ESOP Enhances Growth Visibility; TP Elevated to $29.6 (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
26.08.25 - 14:45
Fosun Pharma Announces 2025 Interim Results (PR Newswire)
 
Enhancing Innovation Efficiency and Steadily Expanding Globally SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; SSE: 600196, HKEX: 02196), a leading innovation-driven global healthcare company,......
12.08.25 - 04:15
FOSUN PHARMA Surges 7%+ at Open; Potential Value of Overseas Licensing for Small-Molecule Oral DPP-1 Inhibitor Totals USD645M (AAStocks)
 
FOSUN PHARMA (02196.HK) opened up 7.55% today and once peaked at HKD21.16. It last traded at HKD20.66, up 6.83%, on a volume of 6.4764 million shares and a turnover of HKD135 million.The company announced yesterday (11th) that its controlling subsidiary, Fosun Pharmaceutical Industrial, has granted Expedition the rights to devel......
12.08.25 - 04:00
H Shrs: HSI Loses 82Pts at Open; BABA-W Soft; FOSUN PHARMA Rebounds (AAStocks)
 
Following a joint U.S.-China statement announcing a further 90-day suspension of reciprocal 24% tariffs, Hong Kong bourse opened lower as markets awaited U.S. inflation data. The HSI dipped 82 points or 0.3% to 24,824, the HSCEI dropped 30 points or 0.3% to 8,858, and the HSTECH declined 32 points or 0.6% to 5,427.For techs, BAB......
12.08.25 - 03:39
Fosun Pharma′s Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million (PR Newswire)
 
SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) to grant Expedition the rights to develop, manufacture, and......
23.07.25 - 23:39
XFRA: DIVIDEND/INTEREST INFORMATION - 24.07.2025 - EQUBF_01 (XETRA)
 
Das Instrument 08HH CNE100001M79 SHANG.FOS.PHARM.GR.H YC 1 EQUITY wird ex Dividende/Zinsen gehandelt am 24.07.2025 The instrument 08HH CNE100001M79 SHANG.FOS.PHARM.GR.H YC 1 EQUITY has its ex-dividend/interest day on 24.07.2025...
26.06.25 - 12:57
Fosun Pharma prices $34.25M Nature’s Sunshine share sale (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.06.25 - 12:33
Nature′s Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock (GlobeNewswire EN)
 
LEHI, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (“Nature's Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the pricing of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”). The shares of common stock are being sold at a price of $12.00 per share. The offering is expected to close on June 27, 2025, subject to customary closing conditions....
25.06.25 - 22:03
Nature′s Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock (GlobeNewswire EN)
 
LEHI, Utah, June 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (“Nature's Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”)....
16.06.25 - 15:30
Teva, Shanghai Fosun Partner To Develop TEV-56278 (AFX)
 
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Monday said that they have partnered to develop TEV-56278.Teva's TEV-56278 ut......
16.06.25 - 15:06
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology (PR Newswire)
 
Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data generation for TEV-56278 Partnership leverages......
06.06.25 - 11:15
FOSUN PHARMA Repurchases 800K A-Shrs, Involving ~RMB20M (AAStocks)
 
FOSUN PHARMA (02196.HK)(600196.SH) announced that it repurchased a total of 800,300 shares of the company on the Shanghai Stock Exchange today (6th), with the price per share ranging from RMB24.92 to RMB25.14, involving a total of approximately RMB19.9988 million. ~AASTOCKS Financial NewsWebsite: www.aastocks.com...
30.05.25 - 09:15
FOSUN PHARMA Once Surges 10%+; Subsidiary's Luvometinib Tablets Receives Drug Registration Approval (AAStocks)
 
FOSUN PHARMA (02196.HK) opened up 2.27% today (30th) and once surged by 10.3% to a peak of HKD16.5. It last traded at HKD16.38, up 9.49%, on a volume of 30.4045 million shares, involving HKD488 million.Shanghai Fosun Pharmaceutical Industrial, a subsidiary of Fosun Pharmaceutical, has received approval from China's National ......
12.05.25 - 07:15
Research: Citi Lists H-shrs w/ US Exports (Table) (AAStocks)
 
Stock│Forecast for Percentage of Revenue from Export to US in 2025COWELL (01415.HK)│30%ASMPT(00522.HK)│15%BYD ELECTRONIC (00285.HK)│around 25-30%.KLN (00636.HK)│15-20%AAC TECH (02018.HK)│12%FOSUN PHARMA (02196.HK)│11%SUNNY OPTICAL (02382.HK)│9%Q TECH (01478.HK)│<1%CHERVON ......
29.04.25 - 03:45
FOSUN PHARMA Clinches Strategic Partnership with Fakeeh Care Group to Extend Product Reach to Mideast (AAStocks)
 
FOSUN PHARMA (02196.HK) announced a strategic partnership with Saudi Arabia’s Fakeeh Care Group, an integrated healthcare group, to jointly promote biologics, CAR-T cell therapies, and other cutting-edge treatments in Saudi Arabia, accelerating local medical innovation. Guo Guangchang, Chairman of Fosun International, expr......
27.03.25 - 15:37
Shanghai Fosun Pharmaceutical reports FY results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.03.25 - 03:30
Fosun Pharma Announces 2024 Annual Results (PR Newswire)
 
Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global......
14.03.25 - 15:18
Fosun Pharma to sell $124m stake in hospital chain to Warburg Pincus (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
26.02.25 - 13:03
Tenapanor Approved in China for Hyperphosphatemia (GlobeNewswire EN)
 
Ardelyx to receive $5 million milestone payment from Fosun Pharma following approval Ardelyx to receive $5 million milestone payment from Fosun Pharma following approval...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Mittelmaß . . . Die übliche Ballungszone des menschlichen Geistes. - Julio Cortázar
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!